Rogers Andrew J, Lockhart Daniel S, Clarke Rebecca, Bennett Helen V, Kadoom Yassar, Turner James E, Dryden Matthew, Crow Matthew A
Momentum Bioscience Ltd, Oxon, UK.
Hampshire Hospitals Foundation Trust, Winchester, UK.
J Appl Lab Med. 2019 Jan;3(4):534-544. doi: 10.1373/jalm.2018.027706. Epub 2018 Nov 20.
Currently it can take up to 5 days to rule out bloodstream infection. With the low yield of blood cultures (approximately 10%), a significant number of patients are potentially exposed to inappropriate therapy that can lead to adverse events. More rapid rule out can accelerate deescalation or cessation of antimicrobial therapy, improving patient outcomes.
A method is described, termed enzymatic template generation and amplification (ETGA), that universally and sensitively detects DNA polymerase activity liberated from viable bacteria and fungi isolated from blood culture samples as a measure of bloodstream infection. ETGA was applied in a diagnostic test format to identify negative blood cultures after an overnight incubation. Performance data for a prototype (Cognitor) and automated (Magnitor) version of the test are presented.
The Cognitor manual assay displayed analytical reactivity for a panel of the 20 most prevalent causes of bloodstream infection, with a detection range of 28-9050 CFU/mL. Validation with 1457 clinical blood cultures showed a negative predictive value of 99.0% compared to blood culture incubation for 5 days. Magnitor showed an improved detection range of 1-67 CFU/mL, allowing for detection of bacteria-supplemented blood cultures after 2-8 h incubation, and -supplemented blood cultures at 16-22 h, 5-15 h faster than blood culture. Removing an aliquot from a blood culture bottle and replacing the bottle into the incubator was shown not to result in contaminating organisms being introduced.
The described method displays excellent breadth and detection for microbial cells and demonstrates the capability of confirming negative blood cultures after an overnight incubation in a blood culture instrument.
目前排除血流感染可能需要长达5天的时间。由于血培养的阳性率较低(约10%),大量患者可能会接受不恰当的治疗,从而导致不良事件。更快地排除感染可以加速抗菌治疗的降阶梯或停止,改善患者预后。
本文描述了一种称为酶促模板生成与扩增(ETGA)的方法,该方法可普遍且灵敏地检测从血培养样本中分离出的活菌和真菌释放的DNA聚合酶活性,以此作为血流感染的一项指标。ETGA以诊断测试形式应用于过夜培养后的血培养阴性鉴定。文中给出了该测试的原型(Cognitor)和自动化版本(Magnitor)的性能数据。
Cognitor手动检测方法对20种最常见的血流感染病因的一组样本显示出分析反应性,检测范围为28 - 9050 CFU/mL。对1457份临床血培养样本进行验证,与5天血培养孵育相比,其阴性预测值为99.0%。Magnitor的检测范围有所改善,为1 - 67 CFU/mL,能够在孵育2 - 8小时后检测添加细菌的血培养样本,以及在16 - 22小时检测添加真菌的血培养样本,比血培养快5 - 15小时。从血培养瓶中取出一份等分试样后再将瓶子放回培养箱,结果表明不会引入污染微生物样本。
所描述的方法对微生物细胞具有出色的检测广度和检测能力,并证明了在血培养仪器中过夜培养后确认血培养阴性的能力。